A Phase I/II Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)

Clinical trial NCT01595087 · COMPLETED

Trial details

NCT number: NCT01595087
Sponsor: DexTech Medical AB
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic

Start date: 2012-01-01
Primary completion: 2013-06-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.